Holen Sie sich die Stockscreener-App
1.0406
3.67%
-0.0494
Handel nachbörslich:
1.06
0.0194
+1.86%
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
13.07%
11.22
|
9.921 | 6.094 | 5.584 | 12.96 |
| Depreciation and Amortization |
86.84%
0.04
|
0.304 | - | 0.001 | 0.017 |
| Operating Income/Loss |
13.07%
-11.22
|
-9.921 | -6.094 | -5.584 | -12.96 |
| Income/Loss From Continuing Operations Before Tax |
25.73%
-11.12
|
-8.843 | -5.351 | -4.886 | -12.50 |
| Income Tax Expense/Benefit |
93.03%
0.031
|
0.445 | - | - | -0.248 |
| Income/Loss From Continuing Operations After Tax |
20.04%
-11.15
|
-9.288 | -5.351 | -4.886 | -12.25 |
|
Net Income/Loss
|
25.35%
-11.15
|
-8.894 | -5.351 | -4.886 | -12.25 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,219%
43.01
|
1.2959 | 36.07 | 35.92 | 35.86 |
| Diluted Average Shares |
3,219%
43.01
|
1.2959 | 36.07 | 35.92 | 35.86 |
| Basic Earnings Per Share |
23.81%
-0.26
|
-0.21 | -0.15 | -0.14 | -0.34 |
| Diluted Earnings Per Share |
23.81%
-0.26
|
-0.21 | -0.15 | -0.14 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
6.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):